GLIMPIFERN-PM1 IMAGE
Glimpifern-PM1 Tablet ER is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels.
GLIMPIFERN-M 1 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
GLIMPIFERN-M 2 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
GLIMPIFERN-PM2 Tablet ER is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels.
GLIMPIFERN 1 MG Tablet belongs to a group of medicines called sulfonylureas and is used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes thereby preventing serious complications of diabetes such as kidney damage and blindness.
GLIMPIFERN 2 Tablet belongs to a group of medicines called sulfonylureas and is used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes thereby preventing serious complications of diabetes such as kidney damage and blindness.
TENEGLIFERN 20 Tablet is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. This helps to prevent serious complications of diabetes like kidney damage and blindness.
TENEGLIFERN-M 500 Tablet SR is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may also reduce your chances of having a heart attack or stroke.
VOGLIBOFERN GM 2 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
FERNFLOZIN-D 10 mg Tablet is used alone or in combination with other medicines to treat type 2 diabetes mellitus. It helps control the high blood sugar levels seen in diabetes. This reduces the chances of serious complications of diabetes and also helps prevent heart disease.
FERNFLOZIN-DM 500 Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus. It helps control the high blood sugar levels seen in diabetes. This reduces the chances of serious complications of diabetes and also helps prevent heart disease.
FERNGLIPTIN-VM 500 Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may also reduce your chances of having a heart attack or stroke.
FERNGLIM-M2 Tablet PR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
GLIMPIFERN PM1 Forte must be taken as directed by the doctor and in doses and duration as prescribed. It must be taken with meals, with the first meal of the day.
The use of GLIMPIFERN M1 Tablet is associated with common side effects like hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache.
This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise.
GLIMPIFERN-PM2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-1 is a medication used for the treatment of type 2 diabetes mellitus. It helps to lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-1 typically contains Glimepiride, which is an oral antidiabetic medication belonging to the sulfonylurea class. Glimepiride stimulates insulin release from the pancreas, helping to control blood sugar levels.
GLIMPIFERN-2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver.
GLIMPIFERN-2 typically contains two active ingredients: Glimepiride and Metformin. Glimepiride is a sulfonylurea that stimulates insulin release from the pancreas, while Metformin is a biguanide that reduces glucose production in the liver and enhances insulin sensitivity.
TENELGLIFERN-20 is a medication used for the treatment of type 2 diabetes mellitus. It helps to lower blood sugar levels by increasing insulin sensitivity and reducing glucose production in the liver.
TENELGLIFERN-20 typically contains Teneligliptin (20 mg), which is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Teneligliptin works by inhibiting the enzyme DPP-4, which increases the levels of incretin hormones. These hormones help to stimulate insulin release and suppress glucagon secretion, leading to improved blood sugar control.
VOGLIBOFERN-GM2 is a medication used for the management of type 2 diabetes mellitus. It helps to control blood sugar levels by enhancing insulin sensitivity and reducing glucose production in the liver.
VOGLIBOFERN-GM2 typically contains Voglibose and Metformin. Voglibose is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates in the intestine, thereby lowering postprandial blood sugar levels. Metformin is a biguanide that reduces glucose production in the liver and enhances insulin sensitivity in tissues.
Tablet is an enzyme used to reduce pain and swelling associated with conditions like back pain, arthritis, sinusitis, etc.
FERNFLOZIN-D 10 Tablet is a combination of two medicines: Diclofenac and Serratiopeptidase.
FERNFLOZIN-DM 500 is a medication used for the treatment of type 2 diabetes mellitus. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by helping the kidneys remove glucose from the bloodstream and excrete it through urine.
FERNFLOZIN-DM 500 typically contains Dapagliflozin (500 mg) and Metformin (extended-release formulation). Dapagliflozin is an SGLT2 inhibitor that reduces the reabsorption of glucose by the kidneys, while Metformin helps to lower blood sugar levels by reducing glucose production in the liver and improving insulin sensitivity.
FERNGLIPTIN-VM 500 is a medication used for the management of type 2 diabetes mellitus. It helps to lower blood sugar levels by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones. These hormones help to stimulate insulin release and reduce glucagon secretion.
FERNGLIPTIN-VM 500 typically contains Vildagliptin (50 mg) and Metformin (extended-release formulation, 500 mg). Vildagliptin is a DPP-4 inhibitor that helps to enhance insulin secretion in response to meals, while Metformin works by decreasing glucose production in the liver and improving insulin sensitivity in tissues.
FERNGLIN-M2 is a medication used for the treatment of type 2 diabetes mellitus. It helps to control blood sugar levels by combining the effects of two different classes of antidiabetic drugs.
FERNGLIN-M2 typically contains Linagliptin (5 mg) and Metformin (500 mg). Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps to increase insulin secretion and decrease glucagon levels after meals. Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity in tissues.
